Oral Session 1-14C Malignant Lymphoma: Gene Expression (1)

[OS1-14C-1] Advantage of multimodality therapy and the effect of gene mutations for vitreoretinal lymphoma

Kazuki Taoka¹, Ayako Karakawa², Kazuhiro Toyama¹, Rie Tanaka², Yosuke Masamoto¹, Fumihiko Nitta³, Kazuichi Maruyama⁴, Daiju Iwata⁵, Satoru Kase⁵, Kenichi Namba⁵, Daigo Hashimoto⁶, Mineo Kurokawa¹ (1.Hematol, Tokyo Univ, Tokyo, Japan, 2.Ophthalmology, Tokyo Univ., Tokyo, Japan, 3.Ophthalmology, Tohoku University, Sendai, Japan, 4.Innovative Visual Science, Osaka University, Osaka, Japan, 5.Ophthalmology, Hokkaido University, Sapporo, Japan, 6.Hematol., Hokkaido University, Sapporo, Japan)